$MTNB If I could short Abogen I would do it, bigly 1. Their two patents are a modification of the DOTIM cationic lipid (possible IP violation) 2. Their two patents are a modification of Abutus patents on ionic cationic lipids (possible IP violation) 3. Cationic lipids causes toxicity and lower genetic transfections versus Arbutus's safe ionizable cationic lipids (changes positive to neutral and back by pH levels) 4. They use unmodified mRNA which CureVac failed and both Pfizer and Moderna uses modified mRNA 5. They use only 15ug mRNA per dose where CureVac horribly failed with 12ug versus Pfizer at 30ug and Moderna at 100ug Knowledge is power
4
4 Likes